Figure 3. The clinical relevance of core clock genes. (A) The survival plot of RORA gene expression (log-transformed FPKM) in lung adenocarcinoma. (B) The survival plot of CRY2 gene expression (log-transformed FPKM) in lung adenocarcinoma. (C) The survival plot of PER1 gene expression (log-transformed FPKM) in esophageal carcinoma. (D) Correlation between drugs and core circadian clock genes. The full survival plots can be seen in supplementary materials.